Healthcare -
Biotechnology - NASDAQ - US
$ 2.751
14.6 %
$ 132 M
Market Cap
-1.99
P/E
SAVA - CASH & EQUIVALENTS
Cash & Equivalents SAVA - Cassava Sciences, Inc.
121 M
LAST VALUE
-27.96%
2 YEAR CAGR
43.65%
5 YEAR CAGR
9.29%
10 YEAR CAGR